Merrill Lynch feels an OPEC production cut in November could push market share to non-OPEC producers, especially those in the U.S. shales, and that in turn could be big for oilfield services.
Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less volatile and act better than biotechs if the market gets dicey.
These four companies have plenty on their proverbial plates and could be poised to move higher if their near-term and longer-term catalysts play out.
24/7 Wall St. has searched its research database for international integrated oil companies that may be the winners in a race to supply an oil-thirsty China.
In a Jefferies research report, the top growth stock picks for this week are littered with outstanding biotech companies that could be poised for some big moves.
In a recent research note, the analysts at Merrill Lynch make a big move by adding a top utility company to the firm's well-respected US 1 list of stocks to Buy.
In a new research report on internet stocks, the analysts at JPMorgan make the case that owning these market leaders still makes sense despite in some cases almost meteoric rises from the lows in…
The question for many investors who have purchased higher yielding bond proxies like utilities, real estate investment trusts and energy master limited partnerships is what sector will act the best when interest rates tick…
The question for investors getting nervous about the market, the election and the general state of the global macro picture is what stocks will hold up best if we do get hit hard.
The longevity of these four top technology companies that all pay a very solid and increasing dividend is a testament to current and former executives who steered them into new product arenas to compete…
Analysts across Wall Street remain very positive on exploration and production companies that are doing the lion's share of their drilling in the Permian basin in West Texas.
In a recent research note, the analysts at Jefferies make a big move by adding a top technology company to the firm's well respected Franchise Picks list of stocks to Buy.
The sell-offs that hit earlier in the month got some insiders interested in shares, and like the week before, they were out again in force last week.
Once again insiders were making transactions that may be getting done now in an effort to beat the closure of trading windows as third-quarter earnings season approaches.
Investors with a touch more risk appetite may want to look at these three stocks hitting five-year relative lows that still are rated Buy by major Wall Street firms and pay dividends.
If these industries don’t bother you personally, they may have solid portfolio potential, and typically even if the economy gets rocky, they are able to hold their own.
The three biotech stocks featured here are rated Outperform at Wedbush and have at least 100% potential upside to the posted price targets.
Deutsche Bank has a very selective list of top utility stock picks. All make good sense for income investors looking for dividends and relative safety.
Out-of-favor companies are shunned for a variety of reasons, but often those reasons are short-term issues. Products need to be updated, bad headlines, big management changes and more are usually the culprits.
Investor have reason to buy the top players in the oil industry that can hold their ground as oil stays range bound the rest of this year and gradually begins moving higher in 2017.
